ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print February 2, 2006
Eur Respir J 2006, doi:10.1183/09031936.06.00107004
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
27/4/726    most recent
09031936.06.00107004v2
09031936.06.00107004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, M.
Right arrow Articles by Nishimura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, M.
Right arrow Articles by Nishimura, M.


ORIGINAL ARTICLE

Role of macrophage migration inhibitory factor in ovalbumin-induced asthma in rats

M. Kobayashi 1, Y. Nasuhara 1*, A. Kamachi 2, Y. Tanino 1, T. Betsuyaku 1, E. Yamaguchi 3, J. Nishihira 4, M. Nishimura 1

1 First Dept of Medicine
2 Dept of Respiratory Medicine, Oji Municipal General Hospital, Tomakomai
3 Division of Respiratory Medical and Allergy Dept of Internal Medicine, Aichi Medical University School of Medicine, Aichi, Japan
4 Central Research Institute, Hokkaido University School of Medicine, Sapporo

* To whom correspondence should be addressed. E-mail: nasuhara{at}med.hokudai.ac.jp.


   Abstract

Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine and reportedly counteracts the anti-inflammatory effect of endogenous glucocorticoids. There have been only a few reports that demonstrate a potential link between MIF and bronchial asthma. In an attempt to further clarify the precise role of MIF in asthma, we examined the effect of anti-MIF antibody on airway inflammation and airway hyperresponsiveness in an ovalbumin-immunized rat asthma model. Actively immunized Brown-Norway rats received ovalbumin inhalation with or without treatment of anti-MIF antibody. The levels of MIF in bronchoalveolar lavage fluid were significantly elevated after the ovalbumin challenge. An immunohistochemical study revealed positive immunostaining for MIF in bronchial epithelium, even in nonsensitized rats, and the MIF staining in bronchial epithelium was enhanced after the ovalbumin challenge. Anti-MIF antibody significantly decreased the numbers of total cells, neutrophils, and eosinophils in the bronchoalveolar lavage fluid of the ovalbumin-challenged rats, and also attenuated the ovalbumin-induced airway hyperresponsiveness to ovalbumin and methacholine. However, anti-MIF antibody did not affect the level of serum ovalbumin-specific IgE, suggesting that anti-MIF antibody did not suppress immunization itself. These results indicate that MIF plays a crucial role in airway inflammation as well as airway hyperresponsiveness in asthma.

Keywords:  Airway hyperresponsiveness, airway inflammation, asthma, eosinophil, macrophage migration inhibitory factor, ovalbumin




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. K. Park, M. K. Cho, H.-K. Park, K. H. Lee, S. J. Lee, S. H. Choi, M. S. Ock, H. J. Jeong, M. H. Lee, and H. S. Yu
Macrophage Migration Inhibitory Factor Homologs of Anisakis simplex Suppress Th2 Response in Allergic Airway Inflammation Model via CD4+CD25+Foxp3+ T Cell Recruitment
J. Immunol., June 1, 2009; 182(11): 6907 - 6914.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M.-H. Cha, T. Rhim, K. H. Kim, A.-S. Jang, Y.-K. Paik, and C.-S. Park
Proteomic Identification of Macrophage Migration-inhibitory Factor upon Exposure to TiO2 Particles
Mol. Cell. Proteomics, January 1, 2007; 6(1): 56 - 63.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.